HIV

The FDA granted a tentative approval for 2 dosages of abacavir/lamivudine tablets for oral suspension to treat HIV-1 infection in pediatric patients, according to a Mylan, Inc, press release.

Mylan, Inc, announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc, under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide as both a single agent product and in combination with other drugs.

Study finds that HIV drug regimens that exclude efavirenz are as effective as first-line antiretroviral treatment.

Beginning therapy within 12 months of HIV detection associated with lower AIDS risk.

Of the 1.2 million Americans with human immunodeficiency virus in 2011, 70% did not have their condition under control.

Study finds treatment that prevents transmission of virus from mother to child leads to reduced heart performance.

Three-drug regimen will lead to new treatment protocols for transplant patients, study finds.

A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.

A trio of studies from AbbVie provides good news for patients with hepatitis C virus, including those with comorbid HIV or cirrhosis.

Women may need more frequent ART doses to prevent HIV transmission than men, a mathematical model suggests

If approved, it would be Gilead's first single-tablet HIV regimen to contain TAF.

Gilead Sciences, Inc., has submitted a new drug application to the FDA for its investigational single-tablet regimen for HIV infection in adult patients.

Following completion of phase 2 trial, phase 3 enrollment expected to start by end of the year.

An investigational HIV drug developed by Merck exhibited a strong overall safety and efficacy profile in a recently completed phase 2b study.

Discovery offers potential target for future HIV treatments.

Could the key to fighting modern illnesses lie in a disease that was an epidemic centuries ago?

Researchers identify mechanisms that trigger hematopoietic stem cell production.

Antiretroviral therapy provides similar benefits for stimulant users and non-users alike.

The vaccine that prevents illness and death from pneumococcal infection also combats severe antibiotic-resistant disease in young children.

Provides use, cost forecast based on testing, future treatment rates.

Harvoni is comprised of sofosbuvir, a previously approved HCV drug marketed under the brand name Sovaldi, and a new drug called ledipasvir.

Tobacco users have an increased risk of oral human papillomavirus type 16, a sexually transmitted virus that is strongly associated with cervical cancer.

Virus was undetectable for 3 years before researchers discovered viral reservoirs have not disappeared.

Parents who know about the human papillomavirus are not more likely to get their adolescent daughters vaccinated.